330 related articles for article (PubMed ID: 33925632)
1. Theranostic Advances in Breast Cancer in Nuclear Medicine.
Vahidfar N; Aghanejad A; Ahmadzadehfar H; Farzanehfar S; Eppard E
Int J Mol Sci; 2021 Apr; 22(9):. PubMed ID: 33925632
[TBL] [Abstract][Full Text] [Related]
2. Targeted radionuclide therapy: frontiers in theranostics.
Gallivanone F; Valente M; Savi A; Canevari C; Castiglioni I
Front Biosci (Landmark Ed); 2017 Jun; 22(10):1750-1759. PubMed ID: 28410143
[TBL] [Abstract][Full Text] [Related]
3. Radioligand Theranostics in the Management of Neuroendocrine Tumors.
Harris AG; Vinik AI; OʼDorisio TM; OʼDorisio MS
Pancreas; 2020; 49(5):599-603. PubMed ID: 32433395
[No Abstract] [Full Text] [Related]
4. Implications of physics, chemistry and biology for dosimetry calculations using theranostic pairs.
Miller C; Rousseau J; Ramogida CF; Celler A; Rahmim A; Uribe CF
Theranostics; 2022; 12(1):232-259. PubMed ID: 34987643
[TBL] [Abstract][Full Text] [Related]
5. Theranostic Outcomes in Clinical Practice of Oncology: What, So What, Now What? What's More.
Turner JH
Cancer Biother Radiopharm; 2019 Apr; 34(3):135-140. PubMed ID: 30973278
[No Abstract] [Full Text] [Related]
6. Toward Independent Nuclear Medicine, Molecular Imaging, and Theranostic Programs.
Czernin J
J Nucl Med; 2019 Aug; 60(8):1037. PubMed ID: 31371618
[No Abstract] [Full Text] [Related]
7. Theranostic approaches in nuclear medicine: current status and future prospects.
Filippi L; Chiaravalloti A; Schillaci O; Cianni R; Bagni O
Expert Rev Med Devices; 2020 Apr; 17(4):331-343. PubMed ID: 32157920
[No Abstract] [Full Text] [Related]
8. Theranostics in Nuclear Medicine: Emerging and Re-emerging Integrated Imaging and Therapies in the Era of Precision Oncology.
Gomes Marin JF; Nunes RF; Coutinho AM; Zaniboni EC; Costa LB; Barbosa FG; Queiroz MA; Cerri GG; Buchpiguel CA
Radiographics; 2020 Oct; 40(6):1715-1740. PubMed ID: 33001789
[TBL] [Abstract][Full Text] [Related]
9. Nuclear Medicine Cancer Care-Current Status and Future Directions for Radiopharmaceutical Diagnostics and Theranostics for Cancer.
O'Brien SR; Mankoff DA
Cancer J; 2024 May-Jun 01; 30(3):140-141. PubMed ID: 38753747
[No Abstract] [Full Text] [Related]
10. Future of Theranostics: An Outlook on Precision Oncology in Nuclear Medicine.
Langbein T; Weber WA; Eiber M
J Nucl Med; 2019 Sep; 60(Suppl 2):13S-19S. PubMed ID: 31481583
[TBL] [Abstract][Full Text] [Related]
11. Targeted Nanotheranostics for Future Personalized Medicine: Recent Progress in Cancer Therapy.
Jo SD; Ku SH; Won YY; Kim SH; Kwon IC
Theranostics; 2016; 6(9):1362-77. PubMed ID: 27375785
[TBL] [Abstract][Full Text] [Related]
12. Insights into the theranostic value of precision medicine on advanced radiotherapy to breast cancer.
Jiang M; Yang J; Li K; Liu J; Jing X; Tang M
Int J Med Sci; 2021; 18(3):626-638. PubMed ID: 33437197
[TBL] [Abstract][Full Text] [Related]
13. Theranostic and nanotheranostic probes in nuclear medicine.
Drude N; Tienken L; Mottaghy FM
Methods; 2017 Nov; 130():14-22. PubMed ID: 28698069
[TBL] [Abstract][Full Text] [Related]
14. Nuclear medicine in the era of personalised medicine.
Lee ST; Scott AM
Intern Med J; 2018 May; 48(5):497-499. PubMed ID: 29722186
[No Abstract] [Full Text] [Related]
15. Theranostic Radiopharmaceuticals: A Universal Challenging Educational Paradigm in Nuclear Medicine.
Urbain JL; Scott AM; Lee ST; Buscombe J; Weston C; Hatazawa J; Kinuya S; Singh B; Haidar M; Ross A; Lamoureux F; Kunikowska J; Wadsak W; Dierckx R; Paez D; Giammarile F; Lee KH; O JH; Moshe M; Louw L; More S; Nadel H; Lee D; Wahl R
J Nucl Med; 2023 Jun; 64(6):986-991. PubMed ID: 37142302
[No Abstract] [Full Text] [Related]
16. Alpha emitting nuclides in nuclear medicine theranostics.
Miederer M
Nuklearmedizin; 2022 Jun; 61(3):273-279. PubMed ID: 34624903
[TBL] [Abstract][Full Text] [Related]
17. Radiotheranostics - Precision Medicine in Nuclear Medicine and Molecular Imaging.
Duan H; Iagaru A; Aparici CM
Nanotheranostics; 2022; 6(1):103-117. PubMed ID: 34976584
[TBL] [Abstract][Full Text] [Related]
18. Theranostics of prostate cancer: from molecular imaging to precision molecular radiotherapy targeting the prostate specific membrane antigen.
Kulkarni HR; Singh A; Langbein T; Schuchardt C; Mueller D; Zhang J; Lehmann C; Baum RP
Br J Radiol; 2018 Nov; 91(1091):20180308. PubMed ID: 29762048
[TBL] [Abstract][Full Text] [Related]
19. Nuclear medicine theranostics comes of age.
Herrmann K; Kraus BJ; Hadaschik B; Kunikowska J; van Poppel H; N'Dow J; Sartor O; Oyen WJG
Lancet Oncol; 2021 Nov; 22(11):1497-1498. PubMed ID: 34735807
[No Abstract] [Full Text] [Related]
20. The Added Value of Diagnostic and Theranostic PET Imaging for the Treatment of CNS Tumors.
Pruis IJ; van Dongen GAMS; Veldhuijzen van Zanten SEM
Int J Mol Sci; 2020 Feb; 21(3):. PubMed ID: 32033160
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]